| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
42,274 |
37,011 |
$15.42M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
27,806 |
25,009 |
$7.20M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
17,687 |
16,337 |
$3.30M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
12,229 |
10,803 |
$1.33M |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
1,532 |
1,383 |
$931K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
2,399 |
2,131 |
$895K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
884 |
809 |
$462K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,818 |
1,014 |
$217K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,106 |
1,857 |
$137K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,778 |
4,260 |
$124K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,370 |
2,751 |
$119K |
| 71045 |
Radiologic examination, chest; single view |
2,302 |
2,003 |
$107K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,433 |
2,049 |
$88K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
687 |
633 |
$75K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
195 |
179 |
$57K |
| G0399 |
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation |
498 |
458 |
$53K |
| 71046 |
Radiologic examination, chest; 2 views |
1,004 |
887 |
$43K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
79,821 |
67,985 |
$22K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
30 |
27 |
$21K |
| 80053 |
Comprehensive metabolic panel |
78,200 |
67,314 |
$17K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
174 |
25 |
$17K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
28,134 |
24,332 |
$16K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
52 |
48 |
$11K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
15 |
12 |
$6K |
| 36415 |
Collection of venous blood by venipuncture |
46,528 |
38,564 |
$6K |
| G0378 |
Hospital observation service, per hour |
434 |
341 |
$6K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
40 |
36 |
$6K |
| 84484 |
|
9,247 |
5,016 |
$5K |
| 81001 |
|
9,789 |
8,583 |
$5K |
| 84703 |
|
1,864 |
1,721 |
$4K |
| 86900 |
|
44 |
37 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
176 |
159 |
$2K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
14 |
12 |
$1K |
| 70450 |
Computed tomography, head or brain; without contrast material |
17 |
12 |
$1K |
| 83690 |
|
5,235 |
4,704 |
$1K |
| 93017 |
|
20 |
16 |
$1K |
| G0398 |
Home sleep study test (hst) with type ii portable monitor, unattended; minimum of 7 channels: eeg, eog, emg, ecg/heart rate, airflow, respiratory effort and oxygen saturation |
12 |
12 |
$946.56 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,453 |
1,071 |
$684.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
297 |
237 |
$527.00 |
| 93296 |
|
71 |
36 |
$514.89 |
| 87631 |
|
900 |
835 |
$199.68 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
213 |
141 |
$117.12 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
220 |
210 |
$55.45 |
| 83735 |
|
750 |
671 |
$9.38 |
| A9270 |
Non-covered item or service |
20 |
12 |
$7.05 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
984 |
741 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
393 |
342 |
$0.00 |
| 81003 |
|
25 |
24 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
29 |
27 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
13 |
12 |
$0.00 |
| 85610 |
|
61 |
49 |
$0.00 |
| 80305 |
|
19 |
14 |
$0.00 |
| 81025 |
|
12 |
12 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
762 |
704 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
612 |
528 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
743 |
687 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
85 |
80 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
279 |
260 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
493 |
457 |
$0.00 |
| 83880 |
|
30 |
28 |
$0.00 |
| 83605 |
|
172 |
138 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
22 |
12 |
$0.00 |
| 85027 |
|
13 |
13 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
128 |
105 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
41 |
37 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
79 |
65 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12 |
12 |
$0.00 |
| 86901 |
|
44 |
37 |
$0.00 |
| 96376 |
|
14 |
12 |
$0.00 |
| 86850 |
|
44 |
37 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
13 |
12 |
$0.00 |